Budesonide aqueous nasal spray (BANS: Rhinocort ® aqua ™) is effective as monotherapy in stable patients with chronic rhinosinusitis (CRS)

Autor: Lund, V, Black, S, László, Zs, Schrewelius, C, Åkerlund, A
Zdroj: In The Journal of Allergy and Clinical Immunology 2002 109(1) Supplement 1:S290-S290
Databáze: ScienceDirect